|
Market Closed -
Nasdaq
01:30:00 16/06/2026 am IST
|
5-day change | 1st Jan Change | ||
| 23.50 USD | +0.09% |
|
-.--% | +159.10% |
| 17/06 | Assertio Holdings Completes Merger With Zydus Lifesciences | MT |
| 17/06 | Assertio Holdings, Inc. Announces Board and Committee Changes, Effective June 16, 2026 | CI |
| Market Cap | 15Cr 13Cr 13Cr 11Cr 22Cr 1.46TCr 22Cr 152.4Cr 59Cr 746.31Cr 57Cr 56Cr 2.4TCr | P/E 2024 |
-3.79x | P/E 2025 | -1.91x |
|---|---|---|---|---|---|
| Enterprise Value | 13Cr 11Cr 11Cr 9.73Cr 18Cr 1.24TCr 19Cr 129.17Cr 50Cr 632.53Cr 48Cr 47Cr 2.03TCr | EV / Sales 2024 |
0.19x | EV / Sales 2025 | 0.3x |
| Free-Float |
99.05% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Assertio Holdings
| 1 day | +0.09% | ||
| 6 months | +22.33% | ||
| Current year | +159.10% |
| Current year | 9.11 | 23.5 | |
| 1 year | 8.61 | 23.5 | |
| 3 years | 7.71 | 39 | |
| 5 years | 7.71 | 120.15 | |
| 10 years | 7.71 | 1,590 |
| Director | Title | Age | Since |
|---|---|---|---|
Ravi Yadavar
BRD | Director/Board Member | 26 | 16/06/2026 |
Punit Patel
BRD | Director/Board Member | - | 16/06/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 13/05/26 | Don | Chairman | -13,332 | 0.2069% | ||
| 05/05/26 | Free | Chairman | 4,851 | 0.0753% | ||
| 05/05/26 | Free | Director | 4,851 | 0.0753% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.09% | -.--% | +72.26% | -35.26% | 15Cr | ||
| -0.61% | -3.43% | +36.07% | +117.61% | 1,01900Cr | ||
| -1.02% | -5.60% | +35.72% | +64.82% | 62TCr | ||
| +1.11% | -0.58% | +12.36% | +78.27% | 46TCr | ||
| +0.34% | -3.01% | +61.79% | +41.79% | 36TCr | ||
| -0.95% | -4.05% | +20.54% | +40.33% | 33TCr | ||
| -1.46% | -2.89% | +10.57% | +26.54% | 27TCr | ||
| -1.35% | -5.43% | -6.17% | +8.82% | 24TCr | ||
| -1.04% | -2.79% | +35.30% | +54.42% | 22TCr | ||
| -1.87% | -4.10% | +28.44% | +97.54% | 18TCr | ||
| Average | -0.68% | -3.02% | +30.69% | +49.49% | 36.97TCr | |
| Weighted average by Cap. | -0.60% | -3.33% | +29.07% | +71.15% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 12Cr 11Cr 10Cr 9.45Cr 18Cr 1.2TCr 18Cr 125.41Cr 49Cr 614.11Cr 47Cr 46Cr 1.97TCr | 12Cr 11Cr 9.84Cr 8.97Cr 17Cr 1.14TCr 17Cr 119.14Cr 46Cr 583.41Cr 45Cr 44Cr 1.87TCr |
| Net income | -2.16Cr -1.92Cr -1.79Cr -1.63Cr -3.08Cr -207.46Cr -3.11Cr -22Cr -8.39Cr -106.06Cr -8.1Cr -7.93Cr -340.38Cr | -3.04Cr -2.7Cr -2.52Cr -2.3Cr -4.33Cr -292Cr -4.37Cr -30Cr -12Cr -149.28Cr -11Cr -11Cr -479.08Cr |
| Net Debt | -5.98Cr -5.31Cr -4.96Cr -4.52Cr -8.52Cr -574.76Cr -8.6Cr -60Cr -23Cr -293.82Cr -22Cr -22Cr -942.99Cr | -2.32Cr -2.06Cr -1.92Cr -1.75Cr -3.3Cr -222.57Cr -3.33Cr -23Cr -9Cr -113.78Cr -8.69Cr -8.5Cr -365.16Cr |
Employees
53
Sector
Pharmaceuticals
- Stock Market
- Stocks
- ASRT Stock
Select your edition
All financial news and data tailored to specific country editions
















